DNMT3A and coronary artery disorder: The risk of CHD is significantly increased in carriers of DNMT3A, TET2, and ASXL1 CHIP mutations (1.7 to 2.0-fold increase), while JAK2V617 CHIP carriers face an even higher risk of 12.1-fold elevation (24).